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S2 Supplementary Table 2 . Hill slopes ± standard errors for the IC 50 curves shown in Figure 10 .
OATP1B1 OATP1B3 OATP2B1
Atazanavir -2.25±0.14 -0.86±0.10 -1.20±0.30 Vincristine -1.04±0.23 -0.83±0.14 - Supplementary Table 3 . Gene specific primer pairs for amplification and cloning of OATP1B3 and OATP2B1. Restriction sites introduced by the primers are underlined.
Cyclosporin

Gene
Primer sequences SLCO1B3 5'-CTAGGGATCCATGGACCAACATCAACATTT -3' / '5-CTAGCTCGAGTTAGTTGGCAGCAGCATTGT-3'
S3 Supplementary Table 4 . SMILES for the 225 investigated compounds. Mifepristone
Compound Smiles
Oc1ccc ( 
Fc1ccc ( 
COc1ccc ( 
